Search results
Leonard S. Schleifer (born 1953) is an American businessman and is the co-founder and chief executive of the biotechnology company Regeneron Pharmaceuticals.
3 days ago · Learn about Leonard Schleifer, the self-made billionaire who cofounded and leads Regeneron Pharmaceuticals. See his net worth, education, philanthropy, and achievements in the biotech industry.
Leonard S. Schleifer, M.D., Ph.D., founded Regeneron in 1988, and has been a board member and the company’s president and chief executive officer since its inception. He currently serves as board co-Chair.
Leonard S. Schleifer, M.D., Ph.D., founded Regeneron in 1988, and has been a board member and the company’s president and chief executive officer since its inception. He currently serves as board co-chair.
Nov 30, 2021 · Dr. Schleifer discusses the Omicron variant, the effectiveness of monoclonal antibodies, and the need to treat immunocompromised people. He also explains how Regeneron adapts its antibody cocktail to new variants and the challenges of regulatory approval.
Learn about Leonard S. Schleifer, the co-founder and leader of Regeneron, a biotechnology company that develops innovative medicines for various diseases. He is a physician, scientist, entrepreneur and a fellow of the American Association for the Advancement of Science.
The CEO of Regeneron, a biotech company that developed antibody cocktails for COVID-19 and Ebola, is honored as the Businessperson of the Year by Fortune. Learn how Schleifer led his company to achieve remarkable financial and medical success in 2020.
